CEL-SCI Corp CVM:NYSE American

Last Price$2.26AMEX Previous Close - Last Trade as of 8:00PM ET 3/24/23
AMEX 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$2.25 (5)
Ask (Size)$3.10 (15)
Day Low / HighN/A - N/A
Volume233.0 K
  • Latest Stories
  • Commentary and Analysis
--EF Hutton Cuts Price Target on Cel-Sci to $16 From $17, Maintains Buy Rating
8:06AM ET 12/29/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Top Premarket Gainers
8:06AM ET 10/12/2022 MT Newswires

Hempacco (HPCO) shares surged 63% premarket Wednesday after the company reported revenue of about $2.8 million for the six months ended June 30, a 486%...

Cel-Sci Reports Positive Data From Phase 3 Study Of Neoadjuvant Multikine In Locally Advanced Head, Neck Cancer
1:12PM ET 9/12/2022 MT Newswires

Cel-Sci (CVM) reported Monday positive data from a phase 3 study of its Neoadjuvant Multikine injection in terms of tumor response and overall survival in...

Cel-Sci Says Positive Findings From Phase 3 Trial of Head, Neck Cancer Drug Now Published
10:54AM ET 8/19/2022 MT Newswires

Cel-Sci (CVM) said Friday that positive findings from its phase 3 trial of Multikine in head and neck cancer have been published on clinicaltrials.gov per...

--EF Hutton Initiates Cel-Sci With Buy Rating, $17 Price Target
1:42PM ET 4/08/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--EF Hutton Initiates Cel-Sci at Buy with $17 Price Target
11:02AM ET 4/07/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...